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Many chemicals present in food, drug, and the environment may be embryotoxic
and can cause embryo malformation. Embryonic stem cell test (EST) is a novel in
vitro method to detect the embryotoxicity of chemicals. However, current EST based
on cardiac differentiation is limited to its long assay time and complex cell culture and
morphological assessment of cardiomyocytes. Moreover, current EST cannot evalu-
ate drug effects on stem cell differentiation to other cell lineages and suffers from low
predictability of <80 percent. The goal of our research is to develop a high through-
put embryotoxicity screening based on enhanced green fluorescent protein (EGFP)
expression in engineered mouse embryonic stem cells (mESCs) under selected human
promoters of tissue-specific differentiation marker genes, such as Tubb3, VEGFR2,
and Oct4. A proliferation study can be used to compare different culture condi-
tions in that we can decide the optimal conditions for cells to grow. In my research,
protocols for stem cell differentiation and proliferation were optimized for use in es-
tablishing a high throughput embryotoxicity screening platform, which can predict
the embryotoxic potential of tested chemicals based on the green fluorescence from
EGFP expression in mESCs in cell cultures. The optimized culture protocol is critical
to improving mESC differentiation efficiency and should enhance the reproducibility
and accuracy of the embryotoxicity screening platform.
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Chapter 1: Introduction
Many chemicals used in food, drug and industrial products have not been assessed
for their embryotoxicity, which can affect embryonic stem cell differentiation and cause
changes in the development of embryo and result in malformation. Many studies
have shown that exposure to embryotoxic chemicals such as organic solvent during
pregnancy would cause low intrauterine growth rate and low birth weight [1]. What’s
more, using certain drugs during pregnancy can cause birth defects. For example,
thalidomide caused the phocomelia of children in the 1960s [2]. It is thus important
to screen chemicals for embryotoxicity before their uses in drugs, cosmetics, food, etc.
and release to environment.
1.1 Stem cells
There are three kinds of stem cells in general: adult stem cells (ASCs), embryonic
stem cells (ESCs), and induced pluripotent stem cells (iPSCs). ASCs are stem cells
found in the human body, but most of them have specific tasks like hematopoietic stem
cells, which can only become blood cells instead of other tissues. Thus, the application
is limited. When women donate their eggs for research purposes, researchers can
fertilize the eggs in vitro to form embryos and derive the inner cell mass into ESCs.
ESCs have more possibilities than ASCs since ESCs can differentiate into all three
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germ layers: ectoderm, endoderm, and mesoderm. However, there’s some ethical
issues associated with human embryonic stem cells. To get the inner cell mass, the
embryo will be destroyed. In some states, the embryos are considered as a life that
should be respected. Thus, many people think it’s unethical to kill a life to get
the human embryonic stem cells. Induced pluripotent stem cells are the medium in
between adult stem cells and embryonic stem cells. Researchers can insert embryonic
genes into somatic cells to make the somatic cells into ”stem cells”. Although this
method has fewer ethical issues, developments are needed in ensuring the pluripotency
and production iPSCs [3].
IPS techniques are capable of transferring any somatic cells into ES-like cells, but
it has the risk of tumor formation since viral vectors are used to introduce embryonic
genes [4]. Since there are some ethical issues in using human embryonic cells (hESCs)
because deriving hESCs will destroy the embryo [4], it’s a good idea to use mouse
embryonic cells. Human and mouse embryonic stem cells are similar in the expression
of many gene markers, even though humans and mice are different species [5].
1.2 Embryotoxicity testing
To test embryotoxicity, animal models are commonly used according to the Or-
ganization for Economic Cooperation and Development guidelines “prenatal develop-
mental toxicity study” and “reproductive/developmentally toxicity screening test”.
Rabbits, mice, rats, and monkeys are most commonly used in research to determine
LD50, which refers to the median lethal dose [6]. However, it is time-consuming and
complex to do animal experiments, and a large number of sacrifices may be needed
[7]. At least half of the testing animals will be killed to find the LD50 of certain drugs,
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and thus, substitute methods are required to test the toxicity to reduce the cost and
mortality. There are three alternatives in vitro methods to animal testing validated
by the European Center for the Validation of Alternative Methods (ECVAM): whole
embryo culture (WEC), mouse embryonic stem cell test (mEST), and the micromass
(MM) test [8]. The micromass test is testing the chemical in the growing embryo
at normal differentiation [9]. The whole embryo culture uses rat embryos that are
around ten days of gestation and the visceral yolk sac from the embryo [10]. However,
these two methods still need pregnant animals and result in sacrifices. Among them,
the EST using mouse embryonic stem cells (mESCs) D3 and 3T3 fibroblasts is the
only one implemented without sacrificing pregnant animals[11].
ESCs, derived from the inner cell mass in early embryonic development stages,
are highly pluripotent and capable of differentiating into all three germ layers and
various cell lineages [12], and are increasingly used as a novel tool in developmental
risk assessment of environmental toxicants. Three endpoints are evaluated in EST
and used to predict the embryotoxic potential (strong, weak, or none) of chemicals
[13].
Current EST focuses on only one cell lineage, i.e. cardiomyocyte, because the
heart is the first formed organ during organogenesis. EST takes 10 days and requires
visual assessment of cardiomyocyte differentiation, which is not only time-consuming
but also laborious in determining the endpoints [14]. Moreover, current EST cannot
evaluate drug effects on stem cell differentiation to other cell lineages and has a <80%
predictability in the validation studies [15].
Recently, our research group has developed a high throughput (HT) embryotoxic-
ity screening based on mESCs expressing enhanced green fluorescent protein (EGFP)
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driven by a human survivin promoter and cytomegalovirus (CMV) promoter, respec-
tively [16]. The HT screening can monitor EGFP fluorescence as cell response to
chemicals in real time with the engineered mESCs cultured in three-dimensional fi-
brous scaffolds in micro-bioreactors. This HT screening used survivin as the molecular
endpoint and was validated with 9 chemicals with known embryotoxicity.
1.3 Scope of study
Chapter 2 presents proliferation study for comparing the effect of FBS from differ-
ent vendors, effect of gelatin coating, and the growth curve by EGFP and AlamarBlue.
This chapter is the basis of the experiments that we can know which way is better for
the ES cell culture, so the conditions for the assay can be optimized. Proliferation
study also validates the platform of high-throughput screening of EGFP.
Chapter 3 investigated cell differentiation experiments. Besides cardiomyocyte
lineage, we also investigated neural cells since the nervous is essential in cell commu-
nication and respond to the outside environment. Process of optimization as well as
the analysis are included in this this section. The optimized protocol can be used in
the HT screening to achieve reliable results.
1.4 Significance
There are more than 10,000 industrial and emerging chemicals, including many
used in pharmaceuticals, foods, cosmetics, plastics, and pesticides, waiting for em-
bryotoxicity assessments, which will cost billion dollars and more than 30 years to
complete if using animal models. Current EST for embryotoxicity screening does not
sacrifice animal but is limited to only one cell lineage. A multi-lineage differentiation
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strategy with three different molecular marker gene promoters can show how embry-
otoxic chemical may affect (inhibit) ESC differentiation to three different germ layers
or cell lineages. This will overcome the drawbacks of current EST and provide a more
robust and predictive embryotoxicity screening.
1.4.1 Proliferation study
A proliferation study can be used to compare the effects of culture conditions such
as with gelatin-coating or without coating. A proliferation study is also important
when determining the effects of different fetal bovine serum (FBS) from different
vendors and to decide which one is better. Alamar Blue can be used to test cell
proliferation because when it is blue without fluorescence, but it will be reduced to
pink color and has fluorescence after incubation with cells. Compared to counting
cell numbers manually, this method is quick and easy to perform.
1.4.2 Cell differentiation
My research focused on the development (optimization) of ESC differentiation
protocols for use in the HT embryotoxicity screening. ESC growth and differentiation
depends on many factors like temperature, coating, medium, etc. Wrong culture
conditions and procedures would lead to cell death and the failure of the screening.
The protocols available in the literature only contain rough culture steps and must be
refined and optimized for our HT screening system. Optimization of culture protocols
for ESC growth and differentiation is critical to the development of the HT screening
and will help achieve reliable and reproducible results. Through finding the best way
to perform each culture step, chemicals that may have effects on ESC growth and
differentiation can be identified and assessed for their embryotoxic potential.
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Chapter 2: Proliferation Study
2.1 Proliferation study to compare FBS
Proliferation study was performed to compare different fetal bovine serum (FBS)
from different vendors: Sigma FBS, ES FBS, and HI FBS. FBS has growth factors,
hormones, proteins and vitamins, which are important for cell proliferation [17]. ES
FBS refers to embryonic stem-cell FBS from Gibco which is optimal for embryonic
stem cells, and it’s also the most expensive one. HI FBS refers to heat-inactivated
FBS and it’s also from Gibco. Heat-inactivated serum is using heat to inactivate
some complements in the serum and is usually used when working with immune type
cell cultures. Sigma FBS refers to FBS from Sigma-Aldrich, which has similar price
compared to HI FBS. For each experiment, 10 % of FBS was added into the medium,
for example, 4 ml FBS in 40 ml medium.
AlamarBlue was used to test the fluorescence of cells at different days. In this
experiment, Wild type was used to compare the general effects of these 3 FBS. 10 %
Alamarblue medium was used to test the fluorescence, for example, 1 ml of Alamar-
Blue medium has 0.1 ml AlamarBlue with 0.9 ml of medium. AlamarBlue was tested
at exitation wavelength of 535 nm and emission wavelength of 595 nm. After testing
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Table 2.1: Experimental design for comparing FBS
Sigma FBS Sigma FBS Sigma FBS Control
HI FBS HI FBS HI FBS Control
ES FBS ES FBS ES FBS Control
the fluorescence, we can plot the growth curve of cells under each FBS to see the ef-
fects of different FBS. Higher fluorescence values means more AlamarBlue is reduced,
and thus it means there are more cells. For each test, new AlamarBlue medium is
needed. Normal growth medium needs to be replaced by AlamarBlue medium, and
then after testing the fluorescence values in 3 hours, the reduced AlamarBlue medium
needs to be replaced by normal growth medium. For each well, we put 20 thousand
cells and 0.25 ml medium. Initially, for the first trial, we decided to use 0.2 ml of
medium + Alamar blue, however, there were too many cells, so there was no reading
of fluorescence after incubation for 3 hours since the values exceeded the maximum
value of the testing machine. For the second trial, we changed the medium + Alamar
Blue amount to 0.8 ml, and this amount of medium worked well. Table 2.1 is the
experimental design. 3 repeated wells on 24-well plate were used to lower the effect
of random errors, and one control well for each FBS was used.
From Figure 2.1, we can see there is no significant difference in cultures growing
in these 3 FBS.
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Figure 2.1: Fluorescence of different FBS
2.2 Growth curves by EGFP and AlamarBlue
2.2.1 Pre-experiment
96-well plate was used in this pre-experiment. We used four wells to mimic cell
number for four different days, and upper wells using 0.2 ml and lower wells using 0.25
ml medium. EGFP was tested 2 hours after seeding the cells at exitation wavelength
of 485 nm and emission wavelength of 535 nm. 10 % AlamarBlue medium was used,
and Alamar blue fluorescence was test at half an hour, 1 hour, 2 hours, and 3 hours to
compare the effects of incubation time. Instead of 0.8 ml of 10 % AlamarBlue medium,
only maximum of 0.25 ml medium can be added into each well of 96-well plate, thus
it’s important to determine the amount of medium and incubation time before actual
experiments. Table 2.2 shows the experimental design of this pre-experiment. for
upper 5 wells, 0.2 ml was used and for lower 5 wells, 0.25 ml of medium was used,
and gain values of 25 and 35 were used to test the fluorescence. Four wells were used
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to mimic cells in four days, each well is double the number of cells of the previous
well.
Table 2.2: Experimental design for the pre-experiment
20,000 cells 40,000 cells 80,000 cells 160,000 cells Control (Only 0.2ml medium)
20,000 cells 40,000 cells 80,000 cells 160,000 cells Control (Only 0.25ml medium)
(a) 0.2 ml; Gain: 25 (b) 0.25 ml; Gain: 35
(c) 0.25 ml; Gain: 25 (d) 0.25 ml; Gain: 35
Figure 2.2: AlamarBlue fluorescence at different medium volume and gain
From Figure 2.2, we can see that amount of medium doesn’t have a significant
effects on alamar blue fluorescence, and 1 hour is the best incubation time. The yellow
9
dots and trendlines refer to 3 hours incubation, and we can see that the relationship is
not linear anymore, which means there’s not enough alamar blue that can be reduced.
Figure 2.3: EGFP fluorescence at different medium volume
From figure 2.3 we can see that the orange curve which refers to 0.25 ml medium,
has an abnormal trend while fluorescence value should increase when cell number
increases. Considering material usage and error, we decided to use the combination
of 1 hour and 0.2 ml of medium.
2.2.2 First trial
In the first trial of experiment, we decided to use ES-Tubb3-EGFP and ES-CMV-
EGFP cell lines, so that we can exclude the effect of specific cell lines. Each cell
line has 5 wells to lower the chance of errors, and 1 well of control which is same
amount of medium without cells. EGFP and AlamarBlue were tested once a day and
AlamarBlue was tested 1 hour after EGFP.
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Table 2.3: Experimental design for trial 1
Tubb3 20 k 20 k 20 k 20 k 20 k 1 Control
CMV 20 k 20 k 20 k 20 k 20 k 1 Control
Wild type 20 k 20 k 20 k 20 k 20 k 1 Control
However, the result shows that the measurements were too less to have a complete
curve. What’s more, there may be some random error in measuring fluorescence, so
1 control is not enough to lower the effect of random error. Thus, we decided to use
3 controls in the next trial.
Figure 2.4: EGFP growth curve
Figure 2.5: AlamarBlue growth curve
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2.2.3 Second trial
In the second trial, we used the same conditions as trials 1, the only difference
is we decided to measure fluorescence twice or third times a day depending on cell
conditions. Furthermore, we added one more cell line of ES-wild type to provide a
comparison of EGFP for engineered cells and non-engineered cells.
Table 2.4: Experimental design for second trial
Tubb3 20 k 20 k 20 k 20 k 20 k 3 Controls
CMV 20 k 20 k 20 k 20 k 20 k 3 Controls
Wild type 20 k 20 k 20 k 20 k 20 k 3 Controls
Since the same wells of cells were used to measure both EGFP and AlamarBlue,
the fluorescence of EGFP was greatly affected by changing medium too often.
Figure 2.6: Tubb3 growth curves by EGFP and AlamarBlue
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Figure 2.7: CMV growth curves by EGFP and AlamarBlue
2.2.4 Third trial
In the last trial, we changed the experimental design that two sets of different
wells were used for EGFP and AlamarBlue seperately to avoid the effect of medium
change. 3 controls were used to avoid random measurement errors.
Table 2.5: Experimental design for third trial
EGFP Tubb3 20 k 20 k 20 k 20 k 20 k 3 Controls
EGFP CMV 20 k 20 k 20 k 20 k 20 k 3 Controls
EGFP Wild type 20 k 20 k 20 k 20 k 20 k 3 Controls
AB Tubb3 20 k 20 k 20 k 20 k 20 k 3 Controls
AB CMV 20 k 20 k 20 k 20 k 20 k 3 Controls
AB Wild type 20 k 20 k 20 k 20 k 20 k 3 Controls
From Figure 2.8 and 2.9 we can see that the trends of growth curves by EGFP
and AlamarBlue are similar for Tubb3 and CMV cell lines. However, for Wild type in
Figure 2.10, the growth curve by EGFP plateaus at time around 40 hours, and then
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Figure 2.8: Tubb3 growth curve by EGFP and AlamarBlue
Figure 2.9: CMV growth curve by EGFP and AlamarBlue
the curve increased rapidly after certain point. We assumed that when cell number
reaches certain point, the cells will have fluorescence by themselves instead by EGFP
genes at the EGFP wavelength range. This can also proves EGFP can’t be used for
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Figure 2.10: Wild type growth curve by EGFP and AlamarBlue
Wild type cell line since it doesn’t have the EGFP gene. This trend shows that EGFP
is good in modeling cell conditions and thus it’s good in predicting embryotoxicity.
2.3 Proliferation Study for effect of gelatin coating
Proliferation study was also used to test the effect of gelatin coating. The cells
growing in the plates with coating and without coating were similar when observing
under microscope. Thus, proliferation study was performed to evaluate the effect
of gelatin coating to see if it’s necessary. Table 2.6 is the experimental design for
comparing the effects of gelatin coating. 20 thousands cells were seeded into 1 well
of 96-well plate, and 0.2 ml medium was used for each well.
Figure 2.11 shows that the fluorescence values are similar initially, however, after
several days, the fluorescence values deviate. Fluorescence values of gelatin coating
are getting higher than values of without gelatin coating. From this result, we can
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Table 2.6: Experimental design for effects of gelatin coating
Coat Tubb3 20 k 20 k 20 k 20 k 20 k Control
Without Tubb3 20 k 20 k 20 k 20 k 20 k Control
Coat Wild type 20 k 20 k 20 k 20 k 20 k Control
Without Wild type 20 k 20 k 20 k 20 k 20 k Control
(a) Tubb3 (b) Wild type
Figure 2.11: Comparison of gelatin coating
conclude that gelatin coating is good for cell culture that cells can have a better con-
dition to grow. The points for 29 h are off due to errors when measuring fluorescence.
Despite the error, we can still see that the fluorescence values of gelatin coating wells
are higher than the values of without gelatin coating.
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Chapter 3: Cell differentiation
3.1 Neural differentiation
Three different culture media are used for studying ESC neural differentiation.
Medium 1, Dulbecco’s Modified Eagle Medium (DMEM) containing 1 % non-essential
amino acid, 1% penicillin-streptomycin, 0.5% L-glutamine, 0.2% β-mercaptoethanol,
10% fetal bovine serum (FBS), and 0.1% Leukemia inhibitory factor (LIF), is used to
grow ES cells and keep their pluripotency without spontaneous differentiation. The
medium with the same composition but without LIF (Medium 2) is used to start
cell differentiation, while Medium 2 with 0.1 % of 10−4 M retinoic acid for neural
differentiation (Medium 3).
The 4-/4+ protocol was used for ES-Tubb3-EGFP differentiation into neuronal
cells (Zang & Yang, 2013). Retinoic acid of 10-2 M is used for neural differentiation
and diluted into 10-4 M for culture medium. ES-Tubb3-EGFP cells are grown in
6-well plate for 3 days with Medium 1 and on day 4, cells are transferred onto 2
non-adherent 9 cm petri dish with Medium 2 and incubated on an orbital shaker for
4 days. On day 8, retinoic acid is added into Medium 2 and cells are incubated on
an orbital shaker for another 4 days. On day 12, 50 embryo bodies (EBs) are picked
into each well in 6-well plates from one of the petri dishes without adding medium
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and replace the medium in dish 2 with Medium 2. As can be seen in Figure 3.1, long
neural axons appeared after day 18.
(a) EGFP expression (b) Under bright field (c) Under microscope
Figure 3.1: Differentiated neural cells
RT-PCR was then performed on day 27 and it showed Tubb3 (a neural differen-
tiation marker) was highly expressed. Green fluorescence was also detected, which
clearly illustrated the morphology of differentiated neural cells. The green fluores-
cence in the culture can be readily monitored with a spectrofluorometer and used as
indicative for the degree of differentiation, which in turn can be used to assess drug
effect on ESC differentiation. Due to too less number of differentiated cells, we were
not able to test EGFP gene expression of differentiated cell. From Figure 3.2 and 3.3,
we can see that the gene expression of Tubb3 is much higher after differentiation com-
pared to undifferentiated cells, while we still need to test EGFP gene of differentiated
cells to finish the comparison.
However, the cell adhesion on 6-well plate was not good. We waited for 24 hours
after picking EBs into 6-well plate, but the cell aggregates probably were not in a
good health condition. After adding enough amount of medium and observed for few
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(a) Gene expression before differentiation (b) Gene expression after differentiation
Figure 3.2: RT-PCR result
Figure 3.3: ES-Tubb3-EGFP neural differentiation
days, none of the cell aggregates were growing. The factors that may be involved
in cell adhesion include: amount medium added initially, Whether to move cells to
new environment or not, Size of original cells aggregates, Whether to remove all the
medium at once and replace with new medium. Thus we decided to shorten the time
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of adding enough medium. Throughout the experiment, we noticed that it’s better
not to change medium often when it’s on orbital shaker, which means small amount
of cells would be better. When changing medium, we kept the dish in the hood and
allowed EBs to settle to bottom, then removed the supernatant from the dish and
replaced it with 10 ml fresh medium 2.
3.2 Cardiac differentiation
Three different culture media are used for studying ESC cardiac differentiation,
respectively. Medium 1, Dulbecco’s Modified Eagle Medium (DMEM) containing
1 % non-essential amino acid, 1% penicillin-streptomycin, 0.5% L-glutamine, 0.2%
β-mercaptoethanol, 10% fetal bovine serum (FBS), and 0.1% Leukemia inhibitory
factor (LIF), is used to grow ES cells and keep their pluripotency without spontaneous
differentiation. The medium with the same composition but without LIF (Medium
2) is used to start cell differentiation, while Medium 2 with 20 % of FBS for cardiac
differentiation (Medium 3).
3.2.1 First trial
For the first trial, the ES-wild type and cardiomyocyte differentiation protocol
optimized by Hartman et al. (2014) was used. ESC cells grew in Medium 1 for 4
days and the hanging drop method was used in day 5 to create aggregates in Medium
3. For this method, we added 70 drops on each lid of the petri dish with one drop
containing 20 µL medium and 1000 cells like shown in Figure 3.4, and then the dishes
were filled with 7 ml phosphate-buffered saline (PBS). After 3 days, the aggregates
were transferred into another petri dish and Medium 3 was added as the differentiation
medium. After 4 days, each EB was transferred into a 24 well plate and observes the
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Figure 3.4: Hanging drop method
beating of EBs. No beating cells in any of the wells or dishes were observed under
microscope. In this trial, we observed that when we put EBs in petri dishes, they
will adhere to the bottom of the dishes instead of floating in the medium. Thus,
it was hard to find a contact round EB and transfer to the 24-well plate. Hanging
drop method is good in controlling the size of the cell aggregates, but it takes time
to perform and it’s hard to take the cell aggregates out from the lids of the dishes.
Considering the adhesion of cell aggregates and complexity, we decided to use the
orbital shaker method in the second trial.
3.2.2 Second trial
In the second trial, we used ES-VEGFR2-EGFP cell line. The gene expression
of VEGFR2 will increase when the cells are differentiated into cardiac cells, so that
RT-PCR can be performed to test the cell differentiation. However, during the ex-
periments, this cell line got contaminated and failed to have any result. Thus we
changed to ES-OCT4-EGFP cell line.
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Figure 3.5: Cell adhesion on dish
3.2.3 Third trial
Optimized protocol and ES-OCT4-EGFP were used in the third trial. Cells were
growing in medium 1 for 4 days, and on day 5, 50 k cells were seeded into each dish in
medium 2 and put on the orbital shaker for 3 days. On the next day, small aggregates
were found and cell aggregates became larger on the following days. When changing
medium, let the cell aggregates settle down for 5 min, remove the supernatant as
much as possible without picking any cell aggregates. On day 8, medium 3 was
prepared, and medium 2 is replaced by medium 3. In this stage, cell aggregates were
still getting larger. On day 12, EBs were transferred into 24-well plate. One EB
was picked and seeded into one well of 24-well plate. For the upper 12 well, 50 µL
medium was added in each well, and for the lower 12 well, 100 µL medium was added
in each well. 0.5 ml of medium was added to each well the next day in 16 hours to
ensure cells’ proliferation. This amount of time ensured cell aggregates adhesion to
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plates and dishes as well as cell proliferation. Cells were growing after adhered to
plates or dishes but no beating was observed. RT-PCR was performed to test the
gene expression, but due to technical issues, there was no result.
(a) Cell aggregates on day 2 (b) Cell aggregates on day 4
Figure 3.6: Cell aggregates
Cell aggregates were observed the next day on orbital shaker. The shapes of cell
aggregates were rounder and more transparent compared to neural differentiation,
and thus this cell aggregates adhered well on both petri dishes and 24-well plates.
From Figure 3.7a, we can see that when transferring cell aggregates, it was hard to
keep the aggregates intact, so the cell debris may be every where on the well of the
plate. Also, from Figure 3.7b, we can see that even if the EB adhered to the plate, the
adhesion was not good. From Figure 3.8a and 3.8b, the morphology on petri dishes
were better compared to cell adhesion on 24-well plate. This result implies dish may
be a better choice for cell adhesion and differentiation.
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(a) Well 1 (b) Well 2
Figure 3.7: Cell adhesion on 24-well plate
(a) Dish 1 (b) Dish 2
Figure 3.8: Cell adhesion on Petri dishes
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Chapter 4: Conclusion
This thesis presents the optimization of cell differentiation protocols and pro-
liferation study. Chapter 2 presents the improvements in methods and results in
proliferation study. This chapter shows that there was no significant difference in
these 3 FBS that we chose for experiments, and this experiment also implies that we
can use a proliferation study to compare the difference between different reagents.
Comparing the effect of gelatin coating implies that although the morphology of cells
may be similar under a microscope, the long-term growth may be affected since the
fluorescence values deviated more when time increases. Thus it’s important to use
proliferation study to find optimal conditions for cells to grow since it’s hard to de-
termine based on morphology. Growth curves by EGFP and AlamarBlue prove that
trends of fluorescence measured using EGFP were similar to trends of AlamarBlue
fluorescence Thus, it’s a reliable way to determine cell proliferation using EGFP.
In Chapter 3, optimization of cell differentiation is presented. Orbital shaker is
definitely a better method in creating cell aggregates since it’s easy to perform and
efficient. One challenge in this work is that there are too many factors that can affect
cell conditions, so it’s hard to determine what is the real cause of the failures of the
experiments. Thus, the optimized protocols should be easy to perform and have a
high tolerance of random errors.
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Future works include RT-PCR of neural differentiation and cardiac differentiation.
RT-PCR should be performed to test the gene expressions of differentiated cells to
verify the feasibility of the optimized protocols.
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